Baird Equity Opportunity Fund Q2 2025 Commentary
Source: SeekingAlpha
2025-08-28 06:40:00 ET
Portfolio Commentary
Fellow shareholders,
Equities proved resilient during the second quarter despite numerous uncertainties. The Russell 2000 Index clawed back most of its Q1 loss, rising 8.5% in the period. The Equity Opportunity Fund outperformed modestly, posting a net return of 9.6%.*...
Read the full article on Seeking Alpha
For further details see:
Baird Equity Opportunity Fund Q2 2025 Commentary
NeoGenomics Inc.
NASDAQ: NEO
NEO Trading
-0.56% G/L:
$7.955 Last:
564,369 Volume:
$8.05 Open:
NEO Latest News
February 25, 2026 07:05:00 am
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
NEO Stock Data
$1,500,898,492
126,282,494
0.16%
88
N/A
Medical Diagnostics & Screening
Healthcare
US
Fort Myers
